Atalanta Sosnoff Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-103,606
Closed -$48.9M 105
2023
Q4
$48.9M Sell
103,606
-2,981
-3% -$1.38M 1.26% 27
2023
Q3
$46.4M Sell
106,587
-3,212
-3% -$1.46M 1.38% 25
2023
Q2
$48.8M Buy
109,799
+1,240
+1% +$572K 1.32% 26
2023
Q1
$49.9M Sell
108,559
-28,032
-21% -$13.3M 1.45% 29
2022
Q4
$70.1M Sell
136,591
-108,838
-44% -$55.3M 2.16% 13
2022
Q3
$111M Sell
245,429
-4,779
-2% -$2.29M 3.52% 6
2022
Q2
$121M Buy
250,208
+55,470
+28% +$27.4M 3.64% 6
2022
Q1
$95.7M Buy
194,738
+34,557
+22% +$15.8M 2.24% 7
2021
Q4
$74.3M Sell
160,181
-62,057
-28% -$26.1M 1.6% 18
2021
Q3
$82.8M Buy
222,238
+78,319
+54% +$29.8M 1.94% 17
2021
Q2
$54.9M Buy
143,919
+40,960
+40% +$15.7M 1.27% 32
2021
Q1
$37M Buy
102,959
+2,072
+2% +$666K 0.91% 42
2020
Q4
$32.4M Buy
+100,887
New +$31M 0.83% 46
2015
Q4
Sell
-8,845
Closed -$1.24M 96
2015
Q3
$1.24M Buy
+8,845
New +$1.33M 0.04% 77

Other funds holding ELV

Atalanta Sosnoff Capital's ELV Position: Q1 2024 in Review

Atalanta Sosnoff Capital sold out of Elevance Health (ELV) in Q1 2024, closing a stake of 103,606 shares — an estimated $48.9M sold.

Atalanta Sosnoff Capital first reported a position in ELV in Q3 2015 and held it in 14 quarters. The position peaked at $121M in Q2 2022. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

  • Atalanta Sosnoff Capital reported no remaining Elevance Health position as of Q1 2024 after selling out during the quarter.
  • Atalanta Sosnoff Capital sold 103,606 Elevance Health shares in Q1 2024, an estimated $48.9M.
  • Atalanta Sosnoff Capital first reported a position in Elevance Health in Q3 2015 and held it in 14 quarters.
  • Atalanta Sosnoff Capital's Elevance Health position peaked at $121M in Q2 2022.
  • 1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on Atalanta Sosnoff Capital's 13F filing for Q1 2024, filed 14 May 2024.